At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 205 enrolled
Drug / intervention
Metoclopramide Nasal Spray +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase 3 Study of Intranasal Metoclopramide in Women With Symptomatic Diabetic Gastroparesis
In Brief
A Phase 3 clinical trial evaluating Metoclopramide Nasal Spray and Placebo Nasal Spray for Diabetic Gastroparesis. Completed, enrolled 205 participants across 50 sites.
Detailed Summary
The purpose of this study is provide confirmation of the safety and efficacy of Metoclopramide Nasal Spray compared to placebo in reducing the symptoms of diabetic gastroparesis in adult women.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Gastroparesis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 2014
Enrollment StartMar 2014
Primary CompletionMay 2016
Study CompletionJun 2016
TodayJul 2026
First PostedJan 1, 2014
Enrollment StartMar 27, 2014
Primary CompletionMay 27, 2016
Study CompletionJun 27, 2016
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 12.5 years ago
Interventions
Metoclopramide Nasal Spraydrug
nasal spray formulation of metoclopramide
Placebo Nasal Spraydrug
nasal spray formulation with vehicle only